Withdrawn applications
Withdrawn application: Arzerra, ofatumumab: Post-authorisation:
Withdrawn application: Kepnetic, aceneuramic acid: Initial authorisation:
Withdrawn application: Graspa, eryaspase: Initial authorisation:
Withdrawn application: Efgratin, pegfilgrastim: Initial authorisation:
Withdrawn application: Cavoley, pegfilgrastim: Initial authorisation:
